SAB Biotherapeutics Cash Flow Statement (2020-2026) | SABS

Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.57M-10.97M-10.45M-12.75M-15.13M-46.51M-50.77M
Share-based Compensation (Quarter)
0.88M0.65M0.01M0.07M0.58M-1.97M0.00M0.64M0.64M-0.89M0.02M0.60M1.05M-0.34M0.61M5.20M0.80M-2.03M97.40M92.80M
Gains from Investment Securities (Quarter)
-0.00M5.65M-7.85M-1.73M-0.78M-0.04M-0.08M0.36M-0.18M4.73M-5.47M-2.22M-0.01M2.31M-5.04M0.63M-61.60M3.25M0.48M1.11M
Change in Interest Receivables (Quarter)
0.19M0.03M-0.13M-0.04M-0.03M-0.02M0.56M0.39M0.61M0.29M
Cash from Operations (Quarter)
3.80M-4.88M-9.54M-4.45M-7.92M-1.56M-1.61M-4.90M-5.17M-13.45M-10.75M-7.72M-6.29M-9.53M-7.80M-7.15M-13.05M-16.78M-14.27M-9.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.04M0.04M0.04M0.03M0.02M0.02M0.03M0.02M0.02M0.03M0.08M0.02M0.02M0.17M0.02M0.02M0.02M0.02M0.02M0.02M
Depreciation & Amortization (CF) (Quarter)
0.37M0.62M0.64M0.75M0.89M0.90M0.90M0.90M1.00M1.00M1.96M1.00M0.90M0.80M0.80M0.80M0.70M0.75M0.70M0.80M
Change in Working Capital
Change in Receivables (Quarter)
-6.90M-2.20M3.78M-2.17M3.33M-7.39M-4.79M-0.40M-0.36M
Change in Account Payables (Quarter)
-3.26M3.27M0.52M-0.04M-0.49M-2.23M-0.04M-0.32M-0.11M0.24M-0.05M0.13M0.59M0.68M0.14M0.34M0.32M0.11M0.67M
Change in Accured Expenses (Quarter)
1.58M0.28M-0.60M-2.00M0.38M-0.32M-1.73M-0.76M-0.63M1.40M-1.58M-0.07M1.86M-1.44M0.58M1.04M-0.29M-0.39M-1.19M1.83M
Change in Taxes (Quarter)
0.09M
Investing Activities
Capital Expenditures (Quarter)
3.23M2.36M1.36M0.61M0.08M0.12M0.02M0.02M0.09M0.07M0.13M0.05M0.10M0.06M0.26M1.59M
Sales of Property, Plant and Equipment (Quarter)
0.08M0.04M500.000.00M783.00
Change in Acquisitions & Divestments (Quarter)
3.75M10.69M4.74M5.25M11.27M74.60M9.71M
Cash from Investing Activities (Quarter)
-3.23M-2.36M-1.28M-0.61M-0.08M-0.12M-0.02M-0.02M-0.04M-0.07M-31.36M11.22M-1.15M9.33M4.67M5.20M-129.87M-1.71M-65.65M-4.88M
Financing Activities
Other financing activities (Quarter)
-4.17M0.01M0.07M1.00-1.000.00M0.00M59.65M0.02M-3.002.98M0.54M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
2.69M0.76M0.76M0.25M3.75M0.33M0.33M0.11M0.26M0.22M0.22M0.62M-0.53M0.14M0.14M3.00
Change in Capital Stock
Shares Issued (Quarter)
3.72M3.90M5.29M7.45M0.71M9.60M9.94M5.05M1.01M2.07M1.89M3.10M2.97M0.89M2.94M6.75M20.89M1.56M39.83M
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.05M36.03M-6.32M-0.73M-0.29M8.39M-0.36M-0.36M-0.14M67.64M-0.39M-0.32M-0.67M0.22M-0.17M-0.17M168.69M-0.04M89.92M2.36M
Exchange Rate Effect (Quarter)
-0.03M0.03M0.05M-0.29M0.04M0.18M-0.04M-0.40M0.01M0.11M
Change in Cash (Quarter)
0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.14M-42.53M3.21M-8.07M-0.27M-3.26M-1.95M25.73M-18.92M10.02M-12.25M
Free Cash Flow (Quarter)
0.57M-7.24M-10.90M-5.06M-8.00M-1.67M-1.63M-4.92M-5.25M-13.51M-10.88M-7.77M-6.39M-9.59M-7.80M-7.15M-13.05M-16.78M-14.53M-11.43M
Net Cash Flow (Quarter)
0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.12M-42.50M3.18M-8.12M0.02M-3.30M-2.13M25.77M-18.52M10.00M-12.36M